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obtain a satisfactory end-result in each case. Six of the 8
patients treated required at least two general anaesthetics
for either closed or open reduction of the fractures and
the remaining 2 cases (cases 6 and 7), have not been
followed up for a sufficient period to preclude them from
having further operations in the future.
Missing the proximal fracture does not seem to be the
only contributing factor in each case. In spite of the early
diagnosis of the entire injury in 3 cases they still required
2 or 3 operative procedures each. This high number of
operative procedures substantiates the impression that the
methods employed in the present series were not entirely
satisfactory. Only one patient can be claimed to have had
a satisfactory course as regards length of time in hospital
and the number of operative procedures.
It would appear, therefore, that internal fixation of the
neck fracture and traction for the shaft fracture or alter-
natively intramedullary nailing of the shaft fracture with
accurate, stable pinning of the neck fracture, are the best
methods. In a young patient with a pertrochanteric or
intertrochanteric fracture of the hip, coexisting with a
shaft fracture which can be managed satisfactorily by
traction, traction seems to be a perfectly satisfactory
method. It is too soon, unfortunately, to report on the
efficacy of this method (employed in cases 6 and 7). How-
ever, no problems have been encountered thus far.
I should like to thank Dr W. H. F. Kenny, Medical Superin-
tendent of H. F. Verwoerd Hospital, for permission to publish;
Drs I. du Toit, 1. Zaaiman and A. de Klerk for allowing me to
report on their cases; and Profs. G. T. du Toit and I. S. de
Wet for their advice and assistance. I also wish to thank ProL
P. D. de Villiers and the Department of Radiology for the
use of radiographs.
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THE EFFICACY OF A BISMUTH-PROTEIN·COMPLEX COMPOUND IN THE TREATMENT
OF GASTRIC AND DUODENAL ULCERS*
G. WEISS, M.B., CH.B., M.MED. (INT.) (PRET.), Formerly Clinical Trials Physician, Depanment of Internal Medicine,
UniversiTy of Pretoria, AND W. J. SERFONTEIN, M.Se., DR. PHIL. NAT. (LEIDEN), University of PreToria
SUMMARY
In a clinical trial involving a total of 86 patiellls, the effi-
cacy of Bicitropeptide (BCP) in The treatment of gasTric
and duodenal ulcers was investigated. The gastric ulcer
group was treated on a double-blind basis with gastro-
scopic control, while in the duodenal ulcer group radio-
logical evidence and clinical assessment were used as
criteria.
In the gastric ulcer group 60% of the patients were com-
pletely healed, while in a further 33·3% of the patienrs,
The ulcer crater was reduced by more ihan two-thirds of
the original size. In the control group, the corresponding
figures were 8·3% and 4I·6~~. In The duodenal ulcer group
88% of the ulcers were considered completely healed.
The advantages of Bicitropeptide therapy are discussed
and it is concluded that it has a definite place in The treat-
ment of gastric and duodenal ulcer disease.
In spite of dramatic advances in many other fields of
medicine during the past decade or two, the treatment of
gastro-intestinal ulceration has remained much the same
and generally in a fairly unsatisfactory state despite the
appearance of a large variety of new preparations based
on much the same principles as the classical anticholiner-
gics, antacids and sedatives. Difficulties in assessing the
value of new preparations, undesirable side-effects asso-
ciated with the use of various drugs, general discomfort
suffered by ulcer patients as a result of dietary restrictions
and prolonged hospitalization as well as the psychological
factors involved, have all contributed to make significant
advances in this field difficult.
Although bismuth compounds were introduced into
medicine as early as 1785, the value of conventional
bismuth preparations in the treatment of gastric and duo-
"'Date received: 3 November 1970.
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denal ulcers is strictly limited due to the fact that such
preparations are rapidly hydrolysed in the acidic contents
of the stomach to be largely precipitated as insoluble
bismuthyl (BiO) compounds.
The observation by one of us (W.J.S.) that the pepsin
component in the classical 'bismuth and ammonium citrate
solution cum pepsin' may react with the soluble bismuth
compounds present in such solutions to form bismuth-
protein-complexes under certain conditions, led us to
investigate the possible use of such complexes in the
treatment of peptic ulcers. It appeared that under suitable
conditions, bismuth-protein-complexes which are relatively
acid stable may be prepared. The clinical usefulness of
such acid-stable bismuth proteinates in the treatment of
peptic ulcers was demonstrated in animal experiments and
on human patients (unpublished observations).
In a further study of the new class of compounds in-
volving the systematic variation of the different variables
involved, it was conclusively demonstrated that the method
of preparation is critically important. The further observa-
tion that the anti-ulcer activity in such preparations may
be significantly increased by increasing the concentration
of the protein component (pepsin), was of utmost signifi-
cance. It was finally established that optimal activity may
be aC!lieved by giving careful attention to a number of
important variables which included the bismuth and citrate
concentration, _ the type and concentration of proteins
present, the type and concentrati0n of the dye and sugar
components present, the pH of the solution, etc.
It was also established that, depending on the nature of
the protein component used, other ccmpounds present and
the conditions of preparation, a widc variety of soluble
bismuth protei nates differing in their physical, chemical
and pharmacological properties may be prepared. A bis-
muth proteinate preparation (Bicitropeptide) dissolved in
bismuth and ammonium citrate solution, based on these
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principles, has recently become available in South Africa
and in various countries overseas.
The results of a typical analysis of the preparation,
showed the presence of the following constituents in I ml:
bismuth (as Bi) 33'60mg, citric acid 22·40 mg, free NH,
5·10 mg, total N 5·33 mg, protein (by difference) 6·96 mg,
carmine 0'70 mg, and sucrose 55 mg. Different batches had
pH values ranging from 9·2 to 9·8. The complexes present
in the preparation were further characterized with the aid
of physico-chemical methods involving electrophoresis,
ultraviolet spectroscopy, gel filtration and ultracentrifuga-
tion.
MODE OF ACTION
The mechanism of action of Bicitropeptide in the treat-
ment of peptic and duodenal ulcers is assumed at this
stage to be based on the biochemical differences between
the ulcerated, inflamed and regenerating tissues in the ulcer
area and the surrounding normal tissues. Quantitative
differences involving an increased concentration of hexo-
samines, hyaluronic acid, mucopolysaccharides and glyco-
proteins in the ulcer area are involved as well as qualitative
differences in respect of the type of glycoproteins and
acid mucopolysaccharides present. Many of these com-
pounds are known to form insoluble bismuth complexes
with soluble bismuth compounds. In this manner the in-
flamed and regenerating tissue of the ulcer surface which
produces these compounds in much larger quantities and
in a more readily available form for reaction than the
surrounding normal tissues, becomes rapidly covered with
a protecting layer of insoluble, bismuth-containing complex
material. The ulcerous tissue which is thus shielded from
further exposure to the damaging effects of the acidic
gastric juice and pepsin, rapidly heals under the protective
bismuth-containing layer which, by virtue of its bismuth
content, also serves to inactivate traces of trapped pepsin.
Bicitropeptide has no significant antacid and no anti-
cholinergic properties and it acts only in acid medium at
pH 1-5, although the optimal action takes place at pH
values below 4.
Agents aimed at increasing alkalinity such as milk, ant-
acids and anticholinergics are, therefore, contraindicated.
Another important practical aspect is that no strict
dietary restrictions are called for and even moderate con-
sumption of alcohol and tobacco is allowed.
Acute and chronic toxicity trials involving mice, rats,"
guinea-pigs and rabbits have conclusively demonstrated the
absence of any side-effects, even after prolonged admini-
stration of large doses. Under these conditions, no bismuth
could be demonstrated in the various organs of all experi-
mental animals at the end of chronic trials over several
months.
No acute LD50 values could be established due to the
extremely low toxicity of the preparation.*
Histological, haematological and clinical investigations
of organs and blood obtained from all the animals at the
end of the chronic trials showed no abnormalities.
A series of investigations on human patients included
serial barium meals, gastric juice analysis, gastroscopy,
blood counts, sedimentation rate, serum protein .electro-
phoresis, serum calcium, phosphorus, electrolytes, urea,
*Experiments carried out by the Biological Sciences Division of the South
African Bureau of Standards.
uric acid, creatinine, iron and iron-binding capacity. All
investi<>ations were repeated 2 and 6 weeks later. The
blood ~ests and other results showed no change following
long-term therapy.
CLI ICAL TRIALS
In this article the results of a clinical trial of Bicitro-
peptide in 2 d:fferent groups of patients with gastric and
duodenal ulcers are reported. The gastric ulcer group was
treated on a double-blind basis, while the duodenal ulcer
group involved a simple experiment on an outpatie.nt basis.
In the latter case patients were accepted for tnal If an
unequivocal ulcer crater could be seen by the radiologist
on films taken not longer than 2 weeks previously.
In the gastric ulcer group patients with a radiological
diagnosis of peptic ulcer were referred to a special clinic
for treatment and observation. Patients in this group were
admitted to hospital for initial gastroscopy and were
hospitalized for 2 weeks.
The design of the gastric ulcer trial was double-blind in
nature, so that the physicians and radiologists, and also
the physician performing the endoscopies did not know
whether the active or placebo preparation had been given
to any individual patient. Patients were allocated to the two
treatment groups according to a prearranged random order.
The active substance contained 0·160 g/5 ml. The placebo
was similar in colour, taste and consistency (liquidity). The
code was only broken on completion of the trial.
Initially, blood was taken for blood count and electro-
phoresis as well as for the estimation of bilirubin, urea,
uric acid, creatinine, calcium, phosphorus and serum iron.
Investigations were repeated after 2 and 6 weeks. No
evidence of toxicity as reflected in these values was found
even after long-term therapy.
The gastric ulcer group underwent gastric juice analysis
and gastroscopies on two occasions, at the beginning and
at the end of the trial. A barium meal was done on all
patients at intervals of 2, 6 and 12 weeks.
The patients were then allocated a serial number and
the appropriate container of medicine was dispensed by
the hospital pharmacist. (The patient retained his serial
number throughout the trial.) They were instructed to take
a teaspoonful in 4 teaspoonsful of water (5 ml in 20 ml)
-}-hour before each of the three main meals and on re-
tiring. Except for the exclusion of milk, each patient fol-
lowed a normal diet. Nothing was taken orally between
administration of medication and meaItime. No antacids
or anticholinergics were given; smoking was allowed and
the advice was given 'to eat anything that does not hurt
you'.
The gastric ulcer group of patients were treated for 6
weeks, the first two of which were spent in hospital.
Patients were not confined to their beds.
Side-effects of the active substance were negligible, but
blackening of stools and the tongue occurred due to the
formation of variable amounts of bismuth sulphide. A few
patients (approximately 20%) in the duodenal ulcer group
complained of tiredness after 3 - 4 weeks of treatment. This
cou!d not be satisfactorily explained.
RESULTS
1. Casiric Ulcer Croup
This included a total of 28 patients, of whom one was
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TABLE I. THE TWO TREATMENT GROUPS
excluded because she could not tolerate the gastroscopic
examination. Of the remaining 27 patients who were ad-
mitted to the trial, 15 were randomly allocated to the
active and 12 to the placebo treatment. The two treatment
groups were comparable with regard to age, duration of
history and sex (Table I).
BCP group. Of the BCP group (15 cases) 9 showed
complete healing by radiological and gastroscopic examina-
tion; 5 were improved in respect of reduction of ulcer
size by one-third of original diameter and 1 constituted a
failure and still showed the presence of an ulcer after 8
weeks of treatment. The results are summarized in Table
n.
Thus a total of 60 out of 75 maximum attainable score
was achieved in 15 patients (80%) in the BCP group.
Placebo group. Of the placebo group (13 cases) 1 case






14 (9 male, j female-
average age 58·3 yr)
4 years 2 months
Control group
(placebo)
12 (7 male, 5 female-
a verage age 60·0 yr)
4 years 3 months
mained unimproved and 1 was excluded. The results are
summarized in Table 111.
Thus a total of 15 out of 60 maximum attainable score
was achieved in 13 patients (25%) in the control group.
Twelve patients on Bicitropeptide treatment and 3 on
placebo had no complaints during the trial period, while
3 patients on Biciptropeptide and 9 on placebo complained
of pain 1 - 14 days after commencement of the trial.
Of the 15 patients on BCP, only 8 developed black
tongues.
The possibility of complications in the interpretation of
the results due to malignancy in some of the patients in
one or both groups was excluded on the basis of the
gastroscopic examinations (and in some cases biopsies)
before and after the trial which were done on all the
patients, thus the 6 cases in the placebo group which
showed no improvement during the trial were classified as
benign on this basis.
2. Duodenal Ulcer Group
This was a simple trial conSlStmg of 59 patients, of
which 7 had to be excluded for lack of co-operation (they
did not return for control bar:um meals). These patients
were selected on the basis of clinical symptoms suggesting






Patients Reduction in Reduction in
size by t size by t
Age Sex No change diameler diameler Healed Clinical X-ray
43 M 3 1 1
58 M 3 1 1
54 M 2 1
60 M 2 1
78 M 3 1
























"'Scoring of gastroscopic changes: 0 = no change; 1 = reduction by t diameter in size; 2 = reduction by i diameter in size; 3 = healed; + 1 for
disappearance on barium meal examination, and 1 for clinical assessment. Total maximum attainable score = 5.
TABLE m. GASTRIC ULCERS: PLACEBO GROUP*
'For scoring of gastroscopic changes see footnote to Table n.
Palienls Reduction in Reduction in
size by t size by i
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chronic peptic ulceration and positive barium meals. They
were treated as outpatients and received the trial material
together with a sedative or tranquillizer in the form of
diazepam or fluphenazin. Instructions similar to those
given to the gastric ulcer patients were given.
Results were judged on clinical grounds. Disappearance
of pain, heartburn, epigastric discomfort and dyspepsia
were considered significant and the appearance of the ulcer
crater on barium-meal examination was noted. The course
lasted 12 weeks, at which stage control films were taken
(Table IV). The course of treatment was 12 weeks in the
duodenal ulcer group as compared with 6 weeks duration
in the gastric ulcer group, because the former group was
judged on clinical impressions and radiological evidence
TABLE IV. DUODENAL ULCER GROUP (ACTIVE)
No. of cases ..
Male ..
Female
Average age .. . . . .
Average duration of illness before treatment
Number healed
Number not healed ..
Recurrence ..
Referred for surgery ..











without hospitalization, while the latter group was hospi-
talized for at least 2 weeks and the results were assessed
directly by means of gastroscopy.
Of the 52 cases retained in the trial, all but 3 had definite
clinical improvements within the first week of treatment
and the ulcer had disappeared on the control barium-meal
films taken after 12 weeks. Even the case of re-occurrence
and the 2 cases referred for surgery, improved clinically
after 2 weeks. Thus 46 cases healed completely as judged
by clinical and radiological assessment (88%).
On the basis of the results presented here and on further
clinical impressions gained over the past year, we conclude
that BCP-compound has a definite place in the armamen-
tarium of ulcer treatments, the safety factor in the use of
the drug being particularly impressive. It is a new approach
to the peptic ulcer problem, easy to administer, does not
entail any hospitalization or dietary restrictions and has
no side-effects. It has, therefore, many advantages over
established regimens and is of definite clinical value in the
treatment of gastric and duodenal ulcer disease.
We wish to thank Drs J. S. Kallmeyer and R. C. P. M. Mekel
for valuable help in conducting the clinical trials and Med-
Nim (Pty) Limited for making available BCP-eompound (bici-
tropeptide) and placebo.
TYPHOID FEVER IN AN ENDEMIC AREA: A 'GREAT IMITATOR'*
1. M. CHALMERS, B.SC. (HONS.), M.B., CH.B., Edendale Hospital, Pietermaritzburg
SUMMARY
A series of 159 cases of typhoid fever from an endemic
area is presented. Epidemiological and clinical features on
admission are considered. Although the findings in the
majority of cases tally with standard descriptions of the
disease, typhoid fever was included in the differential
diagnosis of only about half of the cases. Typhoid fever
should always be borne in mind when a patient from an
endemic area presents with a pyrexial illness.
Typhoid fever is endemic in the area served by Edendale
Hospital. It is common experience that this disease is not
correctly diagnosed on admission to the wards of this
hospital. The following survey has been made in order to
provide a clinical and laboratory profile of typhoid fever
as seen in this area and to emphasize that typhoid fever
should be considered in the differential diagnosis of many
cases, especially when the patient comes from a 'typhoid
area'.'
MATERIAL
All case records classified as 040 (International Classifica-
tion number for typhoid fever) for the year 1969 were
sought. There were 170 of these, but 11 could not be found,
so 159 were scrutinized. Details of incidence and admission
diagnosis were extracted from all of these. Paediatric cases
(arbitrarily defined in this hospital as under 10 years of
age) were excluded from the study of clinical and labora-
tory features on the grounds that these features in younger
patients tend to differ from those seen in adults.' There
'Date received: 28 December 1970.
tPresent address: The Centre for Rheumatic Diseases, Glasgow, Scotland.
were 30 paediatric cases.
It was originally intended to define observed features on
the basis of the well-recognized features of the
disease. Unfortunately, it proved impossible to extract
any information about the duration of the illness from
most of the available records. Apart from the language
barrier existing between most doctors and patients here,
many patients are themselves uncertain for how long they
have been ill.
Not all the adult cases were originally regarded as
medical: 6 presented with what appeared to be surgical




Seasonal incidence is illustrated in Fig. 1. It can be
seen that the disease occurs throughout the year, but is
most prevalent during the height of summer and least so in
the early spring.
Edendale Hospital admits Bantu and Indian patients, the
ratio of Bantu to Indians in the general hospital popula-
tion being about 10: 1. Among the typhoid cases reviewed
here, there was a single case in an Indian and all the re-
mainder were Bantu. The reasons for this discrepancy
probably include the relatively low socio-economic status
of the Bantu and the fact that many of them live in rural
areas with contaminated rivers as their sole source of
water.
Cases were almost equally distributed between males
(76 patients) and females (83 patients). Age incidence is
illustrated in Fig. 2. Typhoid fever is predominantly a
disease of adolescence and young adulthood: 58·5% of
